{
    "2019-01-23": [
        [
            {
                "time": "2023-10-01",
                "original_text": "These 2 Biotech Stocks Seem Significantly Undervalued",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Stocks",
                        "Undervalued"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "XultophyÂ® now available in Canada to support improved glycemic control, an issue facing 50 per cent of Canadians with type 2 diabetes",
                "features": {
                    "keywords": [
                        "Xultophy",
                        "Canada",
                        "glycemic control",
                        "type 2 diabetes"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}